ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mattia Glauber
Eugenio Quaini
Paolo Ferrazzi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bevilacqua, S.
Right arrow Articles by Ferrazzi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bevilacqua, S.
Right arrow Articles by Ferrazzi, P.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2002;74:2016-2021
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Aortic valve disease with severe ventricular dysfunction: stentless valve for better recovery

Stefano Bevilacqua, MDa*, Jacopo Gianetti, MDa, Andrea Ripoli, PhDa, Umberto Paradossi, MDa, Alfredo Giuseppe Cerillo, MDa, Mattia Glauber, MDa, Marco L. Sacha Matteucci, MDb, Michele Senni, MDb, Amando Gamba, MDb, Eugenio Quaini, MDc, Paolo Ferrazzi, MDb

a Institute of Clinical Physiology, Cardiac Surgery Department, Massa, Italy
b Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy
c Cardiac Surgery Department, Private Hospital Poliambulanza, Brescia, Italy

Accepted for publication July 8, 2002.

* Address reprint requests to Dr Bevilacqua, Ospedale G. Pasquinucci CNR-CREAS, Via Aurelia Sud, Località Montepepe 54100 Massa, Italy
e-mail: bevilacqua{at}ifc.cnr.it

BACKGROUND: Stentless bioprostheses and homografts show better hemodynamic profiles compared with conventional stented bioprostheses and mechanical valves. Few data are available on stentless aortic valve implantation for patients with severe left ventricular dysfunction. The aim of this retrospective study was to assess the potential benefits of stentless aortic valve implantation for patients undergoing isolated aortic valve replacement with left ventricular ejection fraction <= 35%.

METHODS: From November 1988 through March 2000, 53 patients (45 men and 8 women, aged 64.2 ± 15.2 years) with a LVEF <= 35% (mean EF, 28.7 ± 5.4%) underwent isolated, primary aortic valve replacement for chronic aortic valve disease. Twenty patients received stentless aortic valves and 33 patients received conventional stented bioprostheses and mechanical valves. Predictive factors for LVEF recovery at echocardiographic follow-up (36.2 ± 32.1 months) were analyzed by simple and multiple regression analysis.

RESULTS: There were no significant differences between groups in early and late mortality. Stentless aortic valve implantation required a longer aortic cross-clamp time (p = 0.037). The stentless aortic valve group showed a better LVEF recovery (p = 0.016). Stentless aortic valves had a larger indexed effective orifice area compared with conventional stented bioprostheses and mechanical valves (p < 0.0001). A smaller indexed effective orifice area (p = 0.0008), chronic obstructive pulmonary disease (p = 0.015), and implantation of a conventional stented bioprosthesis or mechanical valve (p = 0.016) were related to reduced LVEF recovery by univariate analysis. A larger indexed effective orifice area (p = 0.024) was an independent predictive factor for a better LVEF recovery by multivariate analysis.

CONCLUSIONS: Stentless aortic valve implantation for patients with severe left ventricular dysfunction, even if technically more demanding, is a safe procedure that warrants a larger indexed effective orifice area leading to an enhanced LVEF recovery.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
E. A. Grossi, C. F. Schwartz, P.-J. Yu, U. P. Jorde, G. A. Crooke, J. B. Grau, G. H. Ribakove, F. G. Baumann, P. Ursumanno, A. T. Culliford, et al.
High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted?
Ann. Thorac. Surg., January 1, 2008; 85(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
P. Stelzer
Stentless Aortic Valve Replacement: Porcine and Pericardial
Card. Surg. Adult, January 1, 2008; 3(2008): 915 - 934.
[Full Text]


Home page
Eur Heart JHome page
J. Dunning, R.J. Graham, J. Thambyrajah, M.J. Stewart, S.W.H. Kendall, and S. Hunter
Stentless vs. stented aortic valve bioprostheses: a prospective randomized controlled trial
Eur. Heart J., October 1, 2007; 28(19): 2369 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Chukwuemeka, V. Rao, S. Armstrong, J. Ivanov, and T. David
Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function
Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 133 - 138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.